The availability of PET imaging of Aβ plaques and neurofibrillary tau pathology in the brain, has enabled the detection of the core features of the neuropathology of AD in-vivo, and largely supported the proposed sequence of events from Aβ through tau and neurodegeneration (for reviews:3–5). Here, MAPT is linked to Alzheimer disease.